Has Evelyn Kuang received payments from drug or device companies?

Yes. Drug and device makers reported $7,012 in general payments to Evelyn Kuang across 261 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Evelyn Kuang did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Evelyn Kuang come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Evelyn Kuang

Psychiatric/Mental Health · New York, NYNPI 1588188700

Payments from drug & device makers

$7,012in general payments, 2019–2025

Across 261 payments — averaging $26.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$2K
Teva Pharmaceuticals USA, Inc.$1K
Alkermes, Inc.$924
Lundbeck LLC$636
E.r. Squibb & Sons, L.L.C.$442
Takeda Pharmaceuticals U.S.A., Inc.$374
plus $1K from 8 others

What the payments were for

Food & beverage$7,012100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	74	$2,174
Teva Pharmaceuticals USA, Inc.	47	$1,325
Alkermes, Inc.	42	$924
Lundbeck LLC	30	$636
E.r. Squibb & Sons, L.L.C.	12	$442
Takeda Pharmaceuticals U.S.A., Inc.	16	$374
Otsuka America Pharmaceutical, Inc.	17	$361
Neurocrine Biosciences, Inc.	2	$318
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	9	$188
Sunovion Pharmaceuticals Inc.	5	$103
Vanda Pharmaceuticals Inc.	2	$49
Axsome Therapeutics, Inc.	2	$49
Almatica Pharma LLC	2	$47
Jazz Pharmaceuticals Inc.	1	$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,012 in reported general payments places this provider in the 95th percentile of 2,385 psychiatric/mental health providers in New York.

See all psychiatric/mental health providers in New York →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Austedo XrDeutetrabenazine	14	$127,579
RexultiBrexpiprazole	59	$82,280
AristadaAripiprazole Lauroxil	31	$79,346
VraylarCariprazine Hcl	20	$30,665
Abilify MaintenaAripiprazole	11	$28,098
TrintellixVortioxetine Hydrobromide	56	$27,529
BelsomraSuvorexant	41	$16,742
QuviviqDaridorexant Hcl	13	$6,152
Lurasidone Hcl	18	$4,648
Aripiprazole	78	$3,639
Vilazodone Hcl	26	$2,348
Mirtazapine	99	$1,693
Duloxetine Hcl	140	$1,373
Olanzapine	104	$907
Quetiapine Fumarate	99	$829

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo Xr	$1,325	$127,57914 claims
Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena	$361	$110,37870 claims
Alkermes, Inc.Aristada	$924	$79,34631 claims
AbbVieVraylar	$2,174	$30,66520 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix	$374	$27,52956 claims
Almatica Pharma LLCSertraline Hcl	$47	$615103 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,385 psychiatric/mental health providers in New York.

Other psychiatric/mental health in New York

Mary OlsonNew York$142K
Richard CalladoNew York$47K
Darcy LeonNew York$37K
Angela AnukamNew York$11K
Glenn HannDansville$1.3M
Tammy RussoNiskayuna$568K
Carrie EdickSchenectady$484K
Eric SpronzCentereach$448K
Terry Jo Brooks-DevlinTonawanda$176K
Kevin SiewersStaten Island$155K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →